期刊文献+

缬沙坦联合川芎嗪对血管性痴呆模型大鼠空间学习记忆能力的影响 被引量:1

Effects of coadministration of valsartan and ligustrazine on spatial learning and memory in vascular dementia model rats
下载PDF
导出
摘要 目的比较缬沙坦和川芎嗪单独及联合应用对血管性痴呆(VD)模型大鼠空间学习记忆能力的影响,并探讨其可能的作用机制。方法大鼠ip给予硝普钠2.5mg·kg-1后,夹闭双侧颈总动脉缺血10min,再灌注10min,重复2次,制备VD大鼠模型。VD模型制备后24h,治疗组大鼠于每天上午9:00ig给予缬沙坦8mg·kg-1,川芎嗪25mg·kg-1或缬沙坦+川芎嗪(8+25mg·kg-1),每天1次,连续15d,同时设假手术和模型组。Morris水迷宫检测大鼠空间学习记忆能力;Morris水迷宫实验结束后第2天取海马,逆转录PCR检测海马组织白细胞介素1β(IL-1β)mRNA表达;免疫组织化学法检测海马肿瘤坏死因子α(TNF-α),Bcl-2和Bax蛋白表达。结果末次给药后连续5d进行大鼠定位航行训练,训练的第3,4和第5天,模型组大鼠逃避潜伏期分别为43±19,22±10和(16±7)s,与假手术组32±15,16±8和(10±6)s比较明显延长(P<0.05);第6天,模型组大鼠在平台象限停留时间为(35.3±10.0)s,跨越虚拟平台(3.4±1.7)次,平台象限游程百分比为(30±6)%,与假手术组(6.3±2.5)s,(51±11)次和(38±8)%比较明显降低(P<0.05);模型组大鼠海马组织IL-1βmRNA和海马CA1区TNF-α,Bcl-2和Bax蛋白表达与假手术组比较明显增加(P<0.05)。与模型组比较,第4和第5天,缬沙坦、川芎嗪单用和联合应用组大鼠逃避潜伏期明显缩短,分别为18±9和(13±7)s,18±9和(14±7)s及17±8和(11±7)s(P<0.05,P<0.01);联用组大鼠跨越平台的次数、在平台象限停留的时间及平台象限游程百分比均明显增加,分别为(5.6±1.9)次,(50±8)s和(37±6)%(P<0.05),缬沙坦和川芎嗪单用组上述指标改变不明显;二者联用组海马IL-1βmRNA,TNF-α和Bax蛋白表达均明显降低,Bcl-2蛋白表达明显增强(P<0.01);缬沙坦和川芎嗪单用组海马CA1区Bcl-2蛋白表达增强,Bax蛋白表达降低(P<0.01),海马组织IL-1βmRNA表达无明显变化;缬沙坦组海马CA1区TNF-α蛋白表达减少(P<0.05);川芎嗪组TNF-α蛋白表达无明显改变。结论缬沙坦及川芎嗪可改善VD大鼠学习记忆功能,二者联用作用更加明显。该作用可能与其抑制炎症反应及抑制海马神经元凋亡有关。 OBJECTIVE To investigate the effect of coadministration of valsartan and ligus-trazine on spatial learning and memory in vascular dementia ( VD) rats and the possible mechanism. METHODS A VD model was established by ip giving rats sodium nitroprusside 2. 5 mg·kg-1, followed by ischemia 10 min/reperfusion 10 min via blocking the bilateral carotid artery. After 24 h, the rats were divided into sham,model,valsartan 8 mg·kg-1,ligustrazine 25 mg·kg-1 and valsartan + ligustrazine ( 8 +25 mg·kg-1) groups. The drugs were ig given,once a day for 15 d. The spatial learning and memory ability of VD rats were measured with Morris water maze once daily for 5 d after the last drug administration. On the 6th day,the hippocampal tissue of rats was taken and the expression of interleukin 1β ( IL-1β) mRNA was determined by RT-PCR. The expression of tumor necrosis factor-α ( TNF-α) ,Bcl-2 and Bax proteins in the hippocampal tissue was detected by immunohistochemical method. RESULTS On the 3rd,4th and 5th day after the last drug treatment,the escape latency of rats in VD model group was 43 ±19,22 ±10 and ( 16 ± 7) s,which was obviously increased compared with 32 ± 15,16 ± 8 and ( 10 ± 6) s in the sham group ( P <0. 05) . On the 6th day,the time of rats spent in the target quadrant was ( 35. 1 ±10. 0) s,the number of times of crossing the platform was 3. 4 ± 1. 7,and the run percentage of the target quadrant was ( 30 ±6) % in model group,compared with ( 51 ±11) s ,6. 3 ± 2. 5 and ( 38 ±8) % in the sham group ( P <0. 05) while IL-1β mRNA expression in hippocampal tissue,TNF-α,Bcl-2 and Bax proteins in CA1 area of hippocampus were increased . On the 4th and 5th day,compared with the VD model group,valsartan and ligustrazine given separately or combination could shorten the escape latency,which was 18 ±9 and ( 13 ±7) s,18 ±9 and ( 14 ±7) s,and 17 ±8 and ( 11 ± 7) s,respectively ( P <0. 05,P <0. 01) . Coadministration could increase the number of times rats cross the platform,the time spent in the target quadrant and the run percentage of the target quadrant of rats. They were 5. 6 ± 1. 9,( 50 ± 8) s and ( 37 ± 6) % ,respectively ( P < 0. 05) . However,there was no obvious change in groups given valsartan and ligustrazine separately. The expression of IL-1β mRNA,TNF-α and Bax proteins was obviously reduced and Bcl-2 protein was obviously enhanced in coadministration group ( P < 0. 01) . In the groups given valsartan and ligustrazine separately,the expression of Bax was reduced,and Bcl-2 was enhanced,but IL-1β mRNA expression showed no significant difference. TNF-α expression was decreased in valsartan group,but there was no significant difference in ligustrazine group. CONCLUSION Valsartan and ligustrazine can improve learning and memory abilities in VD model rats,especially in drug combination group. This action may be related to the inhibition of inflammatory reaction and hippocampal neurons apoptosis in rats.
出处 《中国药理学与毒理学杂志》 CAS CSCD 北大核心 2010年第5期326-332,共7页 Chinese Journal of Pharmacology and Toxicology
基金 四川省教育厅重点项目资助(2004A059)~~
关键词 缬沙坦 川芎嗪 血管性痴呆 白细胞介素1Β 肿瘤坏死因子α Bcl-2 BAX valsartan ligustrazine vascular dementia interleukin-1β tumor necrosis factor-α Bcl-2 Bax
  • 相关文献

参考文献3

二级参考文献29

  • 1李巍,张世仪,赵惠敏,严徽瑾.小鼠脑缺血性学习记忆障碍模型的建立[J].基础医学与临床,1995,15(6):46-49. 被引量:53
  • 2李巍,严徽瑾,赵慧敏.脑缺血再灌对小鼠学习记忆的影响及药物防护[J].中国康复医学杂志,1995,10(2):67-69. 被引量:35
  • 3陈云波,张大鹏,冯梅,王奇,程淑意,梁伟雄,温泽淮.人参皂苷Rg1对Aβ_(25-35)诱导的神经细胞核因子-κB活化的影响[J].中国药理学通报,2007,23(5):612-617. 被引量:20
  • 4万选才,现代神经生物学,1999年,537页
  • 5魏估震,中国行为医学科学,1996年,5卷,1期,2页
  • 6周本正,医学技术实用全书,1995年,941页
  • 7杨天祝,河北医学院学报,1992年,13卷,2期,83页
  • 8Holmin S, Mathiesen T. Intracerebral administration of interleukin-β and induction of inflammation, apoptosis, and vasogenic edema. J Neurosurg, 2000,92 ( 1 ) : 108-120
  • 9Vitkovic L, Bockaert J, Jacque C. "Inflammatory" cytokines: neuromodulators in normal brain? J Neurochem, 2000, 74 (2) :457-471
  • 10Bellinger FP, Madamba S, Siggins GR. Interleukin-1β inhibits synaptie strength and long-term potentiation in the rat CA1 hippocampus. Brain Res,1993,628(1-2):227-234

共引文献69

同被引文献21

引证文献1

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部